Trials / Completed
CompletedNCT01684540
Application of Ectoin® Rhinitis Nasal Spray in Patients With Acute Rhinosinusitis
Non-interventional Study: Application of Ectoin® Rhinitis Nasal Spray in Patients With Acute Rhinosinusitis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 66 (actual)
- Sponsor
- Bitop AG · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a comparative, open label, parallel group, non interventional study to further demonstrate the effectiveness and tolerability of Ectoin® Rhinitis Nasal Spray. In addition the effectiveness and safety shall be compared to a Sinupret forte. The patient applies Ectoin® Rhinitis Nasal Spray or takes Sinupret forte according to the instructions for use. The observation takes place over a period of 14 days. Response to treatment is recorded at day 7 and day 14 by the physician and in daily by the patient in a dairy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Medical Device, Drug-like | Ectoin Rhinitis Nasal Spray |
| DRUG | Sinupret forte |
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2012-08-01
- Completion
- 2012-08-01
- First posted
- 2012-09-13
- Last updated
- 2026-01-29
Locations
6 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT01684540. Inclusion in this directory is not an endorsement.